Simbec Research Limited
Merthyr Tydfil
CF48 4DR
Tel: +44 (0) 1443 690977
Fax: +44 (0) 1443 692499
Web: www.simbec.co.uk
We are one of Europe's leading Contract Clinical
Research Organisations (CRO) with over 30 years experience in clinical drug
development specialising in healthy volunteer and patient volunteer studies
(Phase I-IIa).
We have our own 48 bed Clinical Pharmacology Unit (CPU), which has been
optimised for the conduct and management of new chemical entity, First into Man,
Phase I and Proof of Concept studies.
We are committed to quality as shown through our GCP, GLP, GMP and CPA
accreditation.
Group Sector
- First into Man Phase I studies, single and multi
dose tolerability
- Proof of Concept Phase IIa studies
- Pharmacokinetic/ Pharmacodynamic studies
- Bioavailability/ Bioequivalence studies
- Mass Balance/ ADME/ Microdosing studies/ AMS
- Drug-Drug Interaction studies
- QTc studies
- Genotyping/ Phenotyping studies
- Biomarker assays
- Central Laboratory
- Biological Matrix drug analysis including assay
development and validation
- Human Metabolite Identification
- Protocol and Report Writing
- Data Management, Statistics & Pharmacokinetics
- Medical Writing
- Quality Assurance
- Project Management
- Study Monitoring
- Simbec Scintigraphy services
- Simtest dermatological services
Geographical Area
Contact
Alan Woodward, Business Development Manager
| 
